Latest Eva Harris Stories
GAITHERSBURG, Md., April 1, 2015 /PRNewswire/ -- VLP Therapeutics, LLC.
The Bill & Melinda Gates Foundation and the Carlos Slim Health Institute partner to fund UCSF-based FIRST (Fighting Infections through Research, Science and Technology) program; a $6 million
RnRMarketResearch.com adds “EpiCast Report Dengue – Epidemiology Forecast to 2023” to its store.
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma.
A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR’s Singapore Immunology Network (SIgN).
Singapore, Aug 13, 2013 - (ACN Newswire) - A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN).
A protein produced by mast cells in the immune system may predict which people infected with dengue virus will develop life-threatening complications.
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design.
Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive mosquito-borne pathogen.
- an ornament or knob in the shape of a flower